Sarah Boyce is the founder of Avidity Biosciences. Avidity Biosciences has raised $30M in total funding. Latest round: IPO.
Sarah Boyce is a life sciences executive who served as President & CEO of Avidity Biosciences, where she led the company through a significant transformation from Series C financing to an IPO. She also oversaw a historic scientific milestone involving targeted RNA delivery into human muscle.
Full founder directory · Investor directory · Company funding database · Fundraising library